US Stock MarketDetailed Quotes
GLSI Greenwich LifeSciences
- 13.120
- +0.780+6.32%
Close Apr 26 16:00 ET
168.96MMarket Cap-19014P/E (TTM)
13.290High12.300Low27.90KVolume12.570Open12.340Pre Close358.92KTurnover0.48%Turnover RatioLossP/E (Static)12.88MShares21.44052wk High25.23P/B76.68MFloat Cap7.58052wk Low--Dividend TTM5.84MShs Float158.070Historical High--Div YieldTTM8.02%Amplitude3.262Historical Low12.863Avg Price1Lot Size
Greenwich LifeSciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -4.49%-6.48M | 0.73%-2.15M | -16.18%-1.8M | -81.52%-966.98K | 20.06%-1.56M | -44.47%-6.2M | 4.16%-2.17M | -73.23%-1.55M | 11.85%-532.7K | -268.65%-1.95M |
| Net income from continuing operations | -13.63%-8.89M | 1.57%-2.75M | -3.14%-2.39M | -118.26%-1.63M | -7.88%-2.12M | -71.21%-7.83M | -18.21%-2.79M | -168.68%-2.32M | 0.49%-746.07K | -229.92%-1.97M |
| Depreciation and amortization | 0.00%3.61K | 0.00%903 | 0.00%903 | 0.00%903 | 0.00%903 | 0.00%3.61K | 0.00%903 | 0.00%903 | 0.00%903 | 0.00%903 |
| Change In working capital | 125.76%31.5K | -111.51%-2.88K | -148.70%-4.26K | 648.21%65.97K | 81.02%-27.33K | 68.26%-122.27K | 135.78%25.03K | 104.43%8.75K | 41.38%-12.03K | -48.13%-144K |
| -Change in payables and accrued expense | 125.76%31.5K | -111.51%-2.88K | -148.70%-4.26K | 648.21%65.97K | 81.02%-27.33K | 68.26%-122.27K | 135.78%25.03K | 104.43%8.75K | 41.38%-12.03K | -48.13%-144K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -4.49%-6.48M | 0.73%-2.15M | -16.18%-1.8M | -81.52%-966.98K | 20.06%-1.56M | -44.47%-6.2M | 4.16%-2.17M | -73.23%-1.55M | 11.85%-532.7K | -268.65%-1.95M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 0 | 0 | -365.79%-7.54M | 0 | 0 | -2.02M | -342.59%-5.51M |
| Net common stock issuance | --0 | --0 | --0 | --0 | --0 | ---7.54M | --0 | --0 | ---2.02M | -316.39%-5.51M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | --0 | --0 | -365.79%-7.54M | --0 | --0 | ---2.02M | -342.59%-5.51M |
| Net cash flow | ||||||||||
| Beginning cash position | -50.49%13.47M | -41.53%9.14M | -36.33%10.94M | -39.67%11.91M | -50.49%13.47M | -5.08%27.2M | -45.90%15.64M | -42.32%17.19M | -35.07%19.74M | -5.08%27.2M |
| Current changes in cash | 52.84%-6.48M | 0.73%-2.15M | -16.18%-1.8M | 62.16%-966.98K | 79.13%-1.56M | -843.35%-13.74M | -27.52%-2.17M | -73.23%-1.55M | -322.82%-2.56M | -527.68%-7.46M |
| End cash Position | -48.10%6.99M | -48.10%6.99M | -41.53%9.14M | -36.33%10.94M | -39.67%11.91M | -50.49%13.47M | -50.49%13.47M | -45.90%15.64M | -42.32%17.19M | -35.07%19.74M |
| Free cash flow | -4.49%-6.48M | 0.73%-2.15M | -16.18%-1.8M | -81.52%-966.98K | 20.06%-1.56M | -44.47%-6.2M | 4.16%-2.17M | -73.23%-1.55M | 11.85%-532.7K | -268.65%-1.95M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg